{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T00:59:39Z","timestamp":1794013179142,"version":"4.8.0"},"reference-count":35,"publisher":"Oxford University Press (OUP)","license":[{"start":{"date-parts":[[2020,12,23]],"date-time":"2020-12-23T00:00:00Z","timestamp":1608681600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Objectives<\/jats:title>\n                  <jats:p>ANCA-associated vasculitis (AAV) usually involves the renal and respiratory systems, but the paediatric literature on pulmonary manifestations and outcomes is limited. We aimed to describe pulmonary manifestations and outcomes after therapy in a cohort of paediatric AAV (pAAV) patients.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>A retrospective chart review of all patients &amp;lt;19\u2009years presenting to our institution with AAV between 1\/2008 and 2\/2018 was conducted. Patient demographics, clinical presentation, diagnostic testing, therapy and pulmonary outcomes over the first 3\u2009years after presentation were evaluated.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>A total of 38 patients were included; all had ANCA positivity by immunofluorescence. A total of 23 had microscopic polyangiitis (MPA), 13 had granulomatosis with polyangiitis and 2 had eosinophilic granulomatosis with polyangiitis. A total of 30 (79%) had pulmonary manifestations, with cough (73%) and pulmonary haemorrhage (67%) being the most common. Abnormalities were noted in 82% of chest CT scans reviewed, with nodules and ground-glass opacities being the most common. At 6, 12 and 36\u2009months follow-up, respectively, 61.8%, 39.4% and 29% of patients continued to show pulmonary manifestations. Five MPA patients with re-haemorrhage are described in detail.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusion<\/jats:title>\n                  <jats:p>MPA was more common than granulomatosis with polyangiitis, with pulmonary involvement being common in both. MPA patients had more severe pulmonary manifestations. Chest CT revealed abnormal findings in a majority of cases. A subgroup of young MPA patients experienced repeat pulmonary haemorrhage. Treatment modality and response were comparable in different subtypes of AAV, except for this young MPA group. Additional prospective studies are needed to better understand the different phenotypes of pAAV.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/rheumatology\/keaa769","type":"journal-article","created":{"date-parts":[[2020,11,4]],"date-time":"2020-11-04T20:25:36Z","timestamp":1604521536000},"source":"Crossref","is-referenced-by-count":13,"title":["Pulmonary manifestations and outcomes in paediatric ANCA\u2013associated vasculitis: a single-centre experience"],"prefix":"10.1093","author":[{"given":"Edouard","family":"Sayad","sequence":"first","affiliation":[{"name":"Division of Pulmonary Medicine, Baylor College of Medicine"},{"name":"Texas Children\u2019s Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tiphanie P","family":"Vogel","sequence":"additional","affiliation":[{"name":"Texas Children\u2019s Hospital"},{"name":"Division of Rheumatology, Department of Pediatrics"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R Paul","family":"Guillerman","sequence":"additional","affiliation":[{"name":"Texas Children\u2019s Hospital"},{"name":"Department of Radiology, Baylor College of Medicine, Houston, TX, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Spielberg","sequence":"additional","affiliation":[{"name":"Division of Pulmonary Medicine, Baylor College of Medicine"},{"name":"Texas Children\u2019s Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David\u00a0Moreno","family":"McNeill","sequence":"additional","affiliation":[{"name":"Division of Pulmonary Medicine, Baylor College of Medicine"},{"name":"Texas Children\u2019s Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marietta","family":"De Guzman","sequence":"additional","affiliation":[{"name":"Texas Children\u2019s Hospital"},{"name":"Division of Rheumatology, Department of Pediatrics"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gunes","family":"Orman","sequence":"additional","affiliation":[{"name":"Texas Children\u2019s Hospital"},{"name":"Department of Radiology, Baylor College of Medicine, Houston, TX, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuel\u00a0","family":"Silva-Carmona","sequence":"additional","affiliation":[{"name":"Division of Pulmonary Medicine, Baylor College of Medicine"},{"name":"Texas Children\u2019s Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2020,12,23]]},"reference":[{"key":"2020122307093662400_keaa769-B1","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.ejim.2020.01.011","article-title":"ANCA associated vasculitis","volume":"74","author":"Salvador","year":"2020","journal-title":"Eur J Intern Med"},{"key":"2020122307093662400_keaa769-B2","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1136\/ard.2006.054593","article-title":"Development and validation of a consensus methodology for the classification of the ANCA-associated vasculitides and polyarteritis nodosa for epidemiological studies","volume":"66","author":"Watts","year":"2006","journal-title":"Ann Rheum Dis"},{"key":"2020122307093662400_keaa769-B3","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1002\/art.1780330812","article-title":"The American College of Rheumatology 1990 criteria for the classification of vasculitis. Summary","volume":"33","author":"Fries","year":"1990","journal-title":". Arthritis Rheum"},{"key":"2020122307093662400_keaa769-B4","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1136\/ard.2009.116624","article-title":"EULAR\/PRINTO\/PRES criteria for Henoch-Sch\u00f6nlein purpura, childhood polyarteritis nodosa, childhood Wegener granulomatosis and childhood Takayasu arteritis: ankara 2008. Part I: overall methodology and clinical characterisation","volume":"69","author":"Ruperto","year":"2010","journal-title":"Ann Rheum Dis"},{"key":"2020122307093662400_keaa769-B5","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.3899\/jrheum.111352","article-title":"Increased sensitivity of the European Medicines Agency algorithm for classification of childhood granulomatosis with polyangiitis","volume":"39","author":"Uribe","year":"2012","journal-title":"J Rheumatol"},{"key":"2020122307093662400_keaa769-B6","doi-asserted-by":"crossref","first-page":"3413","DOI":"10.1002\/art.24876","article-title":"Classification, presentation, and initial treatment of Wegener\u2019s granulomatosis in childhood","volume":"60","author":"Cabral","year":"2009","journal-title":"Arthritis Rheum"},{"key":"2020122307093662400_keaa769-B7","doi-asserted-by":"crossref","first-page":"2514","DOI":"10.1002\/art.39729","article-title":"Comparing presenting clinical features in 48 children with microscopic polyangiitis to 183 children who have granulomatosis with polyangiitis (Wegener\u2019s): an ARChiVe cohort study","volume":"68","author":"Cabral","year":"2016","journal-title":"Arthritis Rheumatol"},{"key":"2020122307093662400_keaa769-B8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fped.2018.00226","article-title":"Primary vasculitis in childhood: GPA and MPA in childhood","volume":"6","author":"Jariwala","year":"2018","journal-title":"Front Pediatr"},{"key":"2020122307093662400_keaa769-B9","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.1002\/art.40112","article-title":"Early outcomes in children with antineutrophil cytoplasmic antibody\u2013associated vasculitis","volume":"69","author":"Morishita","year":"2017","journal-title":"Arthritis Rheumatol"},{"key":"2020122307093662400_keaa769-B10","doi-asserted-by":"crossref","first-page":"1628","DOI":"10.1136\/annrheumdis-2012-202111","article-title":"Disease activity assessment in childhood vasculitis: development and preliminary validation of the Paediatric Vasculitis Activity Score (PVAS)","volume":"72","author":"Dolezalova","year":"2013","journal-title":"Ann Rheum Dis"},{"key":"2020122307093662400_keaa769-B11","doi-asserted-by":"crossref","first-page":"103208","DOI":"10.1016\/j.jbi.2019.103208","article-title":"The REDCap consortium: building an international community of software platform partners","volume":"95","author":"Harris","year":"2019","journal-title":"J Biomed Inform"},{"key":"2020122307093662400_keaa769-B12","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.jbi.2008.08.010","article-title":"Research electronic data capture (REDCap)-A metadata-driven methodology and workflow process for providing translational research informatics support","volume":"42","author":"Harris","year":"2009","journal-title":"J Biomed Inform"},{"key":"2020122307093662400_keaa769-B13","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1007\/s00467-019-04228-4","article-title":"Epidemiology and clinical features of childhood-onset anti-neutrophil cytoplasmic antibody\u2013associated vasculitis: a clinicopathological analysis","volume":"34","author":"Hirano","year":"2019","journal-title":"Pediatr Nephrol"},{"key":"2020122307093662400_keaa769-B14","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.autrev.2017.11.014","article-title":"Childhood- versus adult-onset ANCA-associated vasculitides: a nested, matched case\u2013control study from the French Vasculitis Study Group Registry","volume":"17","author":"Iudici","year":"2018","journal-title":"Autoimmun Rev"},{"key":"2020122307093662400_keaa769-B15","first-page":"i104","article-title":"Clinical characteristics and outcomes of childhood-onset ANCA-associated vasculitis: a French nationwide study","volume":"30","author":"Sacri","year":"2015","journal-title":"Nephrol Dial Transplant"},{"key":"2020122307093662400_keaa769-B16","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12969-017-0150-8","article-title":"Lung involvement in childhood onset granulomatosis with polyangiitis","volume":"15","author":"Filocamo","year":"2017","journal-title":"Pediatr Rheumatol"},{"key":"2020122307093662400_keaa769-B17","doi-asserted-by":"crossref","first-page":"211","DOI":"10.3109\/03009742.2012.754939","article-title":"Long-term outcome of severe alveolar hemorrhage in ANCA-associated vasculitis: a retrospective cohort study","volume":"42","author":"Hruskova","year":"2013","journal-title":"Scand J Rheumatol"},{"key":"2020122307093662400_keaa769-B18","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1002\/ppul.22793","article-title":"Lung manifestations in MPO-ANCA associated vasculitides in children","volume":"49","author":"Ben Ameur","year":"2014","journal-title":"Pediatr Pulmonol"},{"key":"2020122307093662400_keaa769-B19","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1007\/s00467-005-2063-x","article-title":"Childhood microscopic polyangiitis associated with MPO-ANCA","volume":"21","author":"Peco-Antic","year":"2006","journal-title":"Pediatr Nephrol"},{"key":"2020122307093662400_keaa769-B20","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/j.lpm.2013.01.032","article-title":"L32. ANCA vasculitis over the world. What do we learn from country differences?","volume":"42","author":"Watts","year":"2013","journal-title":"Press Medicale"},{"key":"2020122307093662400_keaa769-B21","doi-asserted-by":"crossref","first-page":"1656","DOI":"10.1093\/rheumatology\/kew232","article-title":"Incidence of ANCA-associated vasculitis in a UK mixed ethnicity population","volume":"55","author":"Pearce","year":"2016","journal-title":"Rheumatology"},{"key":"2020122307093662400_keaa769-B22","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1007\/s10067-014-2617-z","article-title":"ANCA-associated vasculitis in Hispanic Americans: an unrecognized severity","volume":"34","author":"Sreih","year":"2015","journal-title":"Clin Rheumatol"},{"key":"2020122307093662400_keaa769-B23","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/j.jpeds.2004.10.025","article-title":"Pulmonary capillaritis in children: a review of eight cases with comparison to other alveolar haemorrhage syndromes","volume":"146","author":"Fullmer","year":"2005","journal-title":"J Pediatr"},{"key":"2020122307093662400_keaa769-B24","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1542\/hpeds.2015-0281","article-title":"Diffuse alveolar haemorrhage as a manifestation of childhood-onset systemic lupus erythematosus","volume":"6","author":"Singla","year":"2016","journal-title":"Hosp Pediatr"},{"key":"2020122307093662400_keaa769-B25","article-title":"Subclinical Pulmonary Granulomatosis With Polyangiitis With Dramatic Response to Treatment","author":"Silva-Carmona","journal-title":"J Clin Rheumatol 2020; Advance Access published"},{"key":"2020122307093662400_keaa769-B26","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/0002-9343(80)90009-1","article-title":"Functional correlates of lung involvement in Wegener\u2019s granulomatosis: use of pulmonary function tests in staging and follow-up","volume":"69","author":"Rosenberg","year":"1980","journal-title":"Am J Med"},{"key":"2020122307093662400_keaa769-B27","doi-asserted-by":"crossref","first-page":"2855","DOI":"10.3389\/fimmu.2019.02855","article-title":"Personalized Medicine in ANCA-Associated Vasculitis ANCA Specificity as the Guide?","volume":"10","author":"Wallace","year":"2019","journal-title":"Front Immunol"},{"key":"2020122307093662400_keaa769-B28","doi-asserted-by":"crossref","first-page":"108325","DOI":"10.1016\/j.clim.2019.108325","article-title":"Childhood GPA, EGPA, and MPA","volume":"211","author":"Jariwala","year":"2020","journal-title":"Clin Immunol"},{"key":"2020122307093662400_keaa769-B29","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12969-019-0343-4","article-title":"Hallmark trials in ANCA-associated vasculitis (AAV) for the paediatric rheumatologist","volume":"17","author":"Lee","year":"2019","journal-title":"Pediatr Rheumatol"},{"key":"2020122307093662400_keaa769-B30","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1002\/art.22774","article-title":"Clinical features and outcome of paediatric Wegener\u2019s granulomatosis","volume":"57","author":"Akikusa","year":"2007","journal-title":"Arthritis Care Res"},{"key":"2020122307093662400_keaa769-B31","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1056\/NEJMoa0909169","article-title":"Rituximab versus cyclophosphamide in ANCA-associated renal vasculitis","volume":"363","author":"Jones","year":"2010","journal-title":"N Engl J Med"},{"key":"2020122307093662400_keaa769-B32","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1056\/NEJMoa0909905","article-title":"Rituximab versus cyclophosphamide for ANCA-associated vasculitis","volume":"363","author":"Stone","year":"2010","journal-title":"N Engl J Med"},{"key":"2020122307093662400_keaa769-B33","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1093\/rheumatology\/ket381","article-title":"Rituximab for induction and maintenance treatment of ANCA-associated vasculitides: a multicentre retrospective study on 80 patients","volume":"53","author":"Charles","year":"2014","journal-title":"Rheumatology"},{"key":"2020122307093662400_keaa769-B34","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1056\/NEJMoa1803537","article-title":"Plasma exchange and glucocorticoids in severe ANCA-associated vasculitis","volume":"382","author":"Walsh","year":"2020","journal-title":"N Engl J Med"},{"key":"2020122307093662400_keaa769-B35","first-page":"1782","article-title":"The role of neighborhood and individual socioeconomic status in outcomes of systemic lupus erythematosus","volume":"35","author":"Trupin","year":"2008","journal-title":"J Rheumatol"}],"container-title":["Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/rheumatology\/advance-article-pdf\/doi\/10.1093\/rheumatology\/keaa769\/35088085\/keaa769.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/rheumatology\/advance-article-pdf\/doi\/10.1093\/rheumatology\/keaa769\/35088085\/keaa769.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,12,23]],"date-time":"2020-12-23T12:30:30Z","timestamp":1608726630000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/rheumatology\/advance-article\/doi\/10.1093\/rheumatology\/keaa769\/6045474"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12,23]]},"references-count":35,"URL":"https:\/\/doi.org\/10.1093\/rheumatology\/keaa769","relation":{},"ISSN":["1462-0324","1462-0332"],"issn-type":[{"value":"1462-0324","type":"print"},{"value":"1462-0332","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,12,23]]},"article-number":"keaa769"}}